Generation Bio Co (NASDAQ:GBIO) has a beta value of 2.68 and has seen 0.61 million shares traded in the last trading session. The company, currently valued at $27.95M, closed the last trade at $0.42 per share which meant it gained $0.03 on the day or 6.35% during that session. The GBIO stock price is -933.33% off its 52-week high price of $4.34 and 23.81% above the 52-week low of $0.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.57 million shares traded. The 3-month trading volume is 477.07K shares.
The consensus among analysts is that Generation Bio Co (GBIO) is Buy stock at the moment, with a recommendation rating of 1.67. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.25.
Generation Bio Co (NASDAQ:GBIO) trade information
Sporting 6.35% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GBIO stock price touched $0.42 or saw a rise of 8.7%. Year-to-date, Generation Bio Co shares have moved -60.66%, while the 5-day performance has seen it change 7.67%. Over the past 30 days, the shares of Generation Bio Co (NASDAQ:GBIO) have changed -19.19%. Short interest in the company has seen 1.69 million shares shorted with days to cover at 3.79.
Generation Bio Co (GBIO) estimates and forecasts
The company’s shares have lost -83.05% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -71.44%.
5 analysts offering their estimates for the company have set an average revenue estimate of 1.7M for the current quarter. 5 have an estimated revenue figure of 1.7M for the next ending quarter. Year-ago sales stood 4.06M and 4.09M respectively for this quarter and the next, and analysts expect sales will shrink by -58.01% for the current quarter and -71.44% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.30% over the past 5 years. Earnings growth for 2025 is a modest 43.69% while over the next 5 years, the company’s earnings are expected to increase by 25.87%.
GBIO Dividends
Generation Bio Co is expected to release its next earnings report on 2025-Mar-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
Insiders own 14.35% of the company shares, while shares held by institutions stand at 81.56% with a share float percentage of 95.23%. Investors are also buoyed by the number of investors in a company, with Generation Bio Co having a total of 120.0 institutions that hold shares in the company. The top two institutional holders are PRICE T ROWE ASSOCIATES INC /MD/ with over 9.51 million shares worth more than $26.83 million. As of 2024-06-30, PRICE T ROWE ASSOCIATES INC /MD/ held 14.3205% of shares outstanding.
The other major institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, with the holding of over 8.28 million shares as of 2024-06-30. The firm’s total holdings are worth over $23.35 million and represent 12.4628% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are T. Rowe Price New Horizons Fund, Inc. and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . As of Dec 31, 2024 , the former fund manager holds about 7.96% shares in the company for having 5.34 shares of worth $2.23 million while later fund manager owns 1.77 shares of worth $0.74 million as of Feb 28, 2025 , which makes it owner of about 2.65% of company’s outstanding stock.
